Evidence map›Paper›PMID 27623625›Full record

ArticlePharmaceutical research2016

Accessorized DPI: a Shortcut towards Flexibility and Patient Adaptability in Dry Powder Inhalation.

Francesca Buttini, James Hannon, Kristi Saavedra, Irene Rossi, Anna Giulia Balducci, Hugh Smyth, Andy Clark, Paolo Colombo

Abstract read
PubMed Publisher
In one paragraph

Article in Pharmaceutical research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Francesca ButtiniDepartment of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy.
James HannonRespira Therapeutics Inc., Albuquerque, New Mexico, USA.
Kristi SaavedraRespira Therapeutics Inc., Albuquerque, New Mexico, USA.
Irene RossiDepartment of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy.
Anna Giulia BalducciDepartment of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy.
Hugh SmythRespira Therapeutics Inc., Albuquerque, New Mexico, USA.
Andy ClarkRespira Therapeutics Inc., Albuquerque, New Mexico, USA.
Paolo ColomboDepartment of Pharmacy, University of Parma, Parco Area delle Scienze, 43124, Parma, Italy. paolo.colombo@unipr.it.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeIn this work, a novel powder dispersion add-on device, the AOS (Axial Oscillating Sphere), was studied in conjunction with commercially available DPI devices to improve the powder dispersion.

methodsAn ordered mixture of formoterol fumarate and lactose was selected. We studied in two laboratories located at different altitudes the dispensing and dispersion of the drug at different flow rates, paying particular attention to a number of metrics of Fine Particle Dose (FPD).

resultsTwo novel findings emerged from the data collected. First, the aerosol quality, measured as fine particle dose, can be increased by adding the accessory promoting the dispersion and de-aggregation of the formulation. The second finding was that, albeit the emitted dose was independent of altitude, the drug/lactose carrier DPI aerosolizing performance changed with the altitude of testing. In particular, fine particle dose depended on both altitude and device configuration. The RS01 inhaler without the AOS accessory used at higher altitude gave the lowest FPD values. By combining the AOS accessory with the DPI, however, the performance dependence on altitude/atmospheric pressure was essentially removed.

conclusionsIncreasing inhaler performance can be achieved using an add-on accessory that enhances aerosol dispersion and minimizes flow rate dependency.

Indexed as

Administration, InhalationAerosolsDrug CarriersDrug CompoundingDry Powder InhalersEquipment DesignHumansLactoseParticle SizePowdersAerosolsDrug CarriersLactosePowdersatmospheric pressureaxial oscillating spheredry powder inhalerfine particle doseformoterol fumarate

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.